Market Closed -
Other stock markets
|
Pre-market 07:58:18 am | |||
146.8 USD | -1.15% | 147.4 | +0.36% |
Apr. 25 | Redburn Atlantic Adjusts Johnson & Johnson Price Target to $160 From $170 | MT |
Apr. 24 | Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset | DJ |
Financials (USD)
Sales 2024 * | 88.39B | Sales 2025 * | 90.87B | Capitalization | 354B |
---|---|---|---|---|---|
Net income 2024 * | 22.02B | Net income 2025 * | 22.97B | EV / Sales 2024 * | 3.92 x |
Net cash position 2024 * | 7B | Net cash position 2025 * | 21.07B | EV / Sales 2025 * | 3.66 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
15.4
x | Employees | 131,900 |
Yield 2024 * |
3.29% | Yield 2025 * |
3.43% | Free-Float | 77.1% |
Latest transcript on Johnson & Johnson
1 day | -1.15% | ||
1 week | +0.74% | ||
Current month | -7.19% | ||
1 month | -5.41% | ||
3 months | -7.98% | ||
6 months | -3.13% | ||
Current year | -6.33% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 215 M€ | +12.27% | - | |
12.91% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 146.8 | -1.15% | 7,642,732 |
24-04-24 | 148.5 | -0.69% | 9,756,259 |
24-04-23 | 149.6 | +0.30% | 10,110,442 |
24-04-22 | 149.1 | +0.82% | 10,118,694 |
24-04-19 | 147.9 | +1.49% | 9,750,751 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.33% | 354B | |
+24.50% | 556B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.28% | 233B | |
+5.55% | 201B | |
-10.02% | 193B | |
-12.26% | 143B | |
-6.47% | 144B | |
+1.39% | 123B |
- Stock Market
- Equities
- JNJ Stock